top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy
Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy
Autore Ruvo Menotti
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (278 p.)
Soggetto topico Technology: general issues
Soggetto non controllato porcine deltacoronavirus
nucleocapsid
monoclonal antibodies
neurodegenerative disorders
affibody molecules
blood–brain barrier
receptor-mediated transcytosis
transferrin receptor
AL amyloidosis
CD38
anti-CD38 MoAb
Daratumumab
Isatuximab
myeloma
BCMA
bispecific T-cell engager
antibody-drug conjugates
chimeric antigen receptor T-cells
belantamab mafodotin
idecabtagene vicleucel
JNJ-68284528
Mabs
Antibody-Drug Conjugate
cancer therapy
drug targeting
payload
cross-linking
antibody fragment
Fab
scFv
E. coli
YKL-40
CHI3L1
monoclonal antibody
phage display
lung metastasis
prostate-specific membrane antigen
in vivo imaging
prostate cancer
glutamate carboxypeptidase II
NAALADase
immunization
antibody
protocol
guinea pig
cDNA
chimeric antigen receptor (CAR T)
universal CAR T
modular CAR T
universal immune receptor
CAR adaptor
adoptive immunotherapy
split CAR
bispecific
polyspecificity
pharmacokinetics
solubility
aggregation
viscosity
developability
stability
affinity
specificity
protein engineering
self-association
non-specific binding
immunogenicity
antibody fragments
single chain
amyloid
oligomer
neurotoxicity
NUsc1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557613003321
Ruvo Menotti  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances in Antibody Therapeutics
Recent Advances in Antibody Therapeutics
Autore Heo Yong-Seok
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (238 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato interleukin 33
ST2 receptor
scFv
C2_2E12
bladder cancer
antibodies
immune checkpoint inhibitors
antibody-drug conjugates
sacituzumab govitecan
enfortumab vedotin
erdafitinib
cost-effectiveness
G protein-coupled receptor
membrane protein
antigen
therapeutic antibody
anti-angiogenesis
delta-like ligand
irinotecan
paclitaxel
VEGF
SARS-CoV-2
spike protein
receptor-binding domain
phage display
monoclonal antibody
cytomegalovirus
peptide/major histocompatibility complex class I complex
T-cell-receptor-like antibody
affinity maturation
yeast surface display
combinatorial antibody library
agonist antibody
cell fate
bispecific antibodies
bioassays
mechanisms of action
binding assays
potency assays
atherosclerosis
inflammation
antibody therapy
blood-brain barrier
antibody
pharmacokinetics
disposition
biochemical and physicochemical properties
Fc binding
receptor-mediated transcytosis
brain shuttle
molecular Trojan horse
transferrin
anti-cancer antibody
antibody engineering
biophysical properties
computational methods
research cell bank
antibody therapeutics
recombinant antibodies
intracellular antibodies
single-chain antibody fragment
nanobody
Human papillomaviruses
HPV oncoproteins
HPV-associated cancer
HPV cancer therapy
asthma
refractory asthma
biomarker
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580204803321
Heo Yong-Seok  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui